Evidence map›Paper›PMID 30908812›Full record

ArticleIntegrated environmental assessment and management2019

When Are Adverse Outcome Pathways and Associated Assays "Fit for Purpose" for Regulatory Decision-Making and Management of Chemicals?

Katie Coady, Patience Browne, Michelle Embry, Thomas Hill, Eeva Leinala, Thomas Steeger, Lidka Maślankiewicz, Tom Hutchinson

Abstract read
In one paragraph

Article in Integrated environmental assessment and management, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Chemosensory tobacco product toxicology part 2: toxicological testing, assays, and state of the science.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Overview of Adverse Outcome Pathways and Current Applications on Nanomaterials.Advances in experimental medicine and biology · 2022
    Review
  7. Article
  8. Evolving Science and Practice of Risk Assessment.Risk analysis : an official publication of the Society for Risk Analysis · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Toxicity testing is evolving!Toxicology research · 2020
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katie CoadyToxicology & Environmental Research & Consulting, Dow Chemical Company, Midland, Michigan, USA.
Patience BrowneEnvironment, Health and Safety Division, Environment Directorate, Organisation for Economic and Cooperative Development, Paris, France.
Michelle EmbryHealth and Environmental Sciences Institute, Washington, DC, USA.
Thomas HillUS Environmental Protection Agency, National Health and Environmental Effects Research Laboratory, Research Triangle Park, North Carolina.
Eeva LeinalaEnvironment, Health and Safety Division, Environment Directorate, Organisation for Economic and Cooperative Development, Paris, France.
Thomas SteegerUS Environmental Protection Agency, Office of Pesticide Programs, Washington, DC.
Lidka MaślankiewiczNational Institute of Public Health and the Environment (RIVM), Centre for Safety of Substances and Products, Bilthoven, The Netherlands.
Tom HutchinsonUniversity of Plymouth, Plymouth, United Kingdom.

Funding

funding support from the Society of Environmental Toxicology and Chemistry, United States Environmental Protection Agency, American Cleaning Institute, Cefic-LRI (European Chemical Industry Council Long-Range Research Initiative), Chevron-Environmental, ECETOC (European Center for Ecotoxicology and Toxicology of Chemicals), European Commission Joint Research Centre, European Crop Protection, ExxonMobil, Health and Environmental Sciences Institute, Humane Society International, The Humane Society
6 · The paper itself

Abstract

There have been increasing demands for chemical hazard and risk assessments in recent years. Chemical companies have expanded internal product stewardship initiatives, and jurisdictions have increased the regulatory requirements for the manufacture and sale of chemicals. There has also been a shift in chemical toxicity evaluations within the same time frame, with new methodologies being developed to improve chemical safety assessments for both human health and the environment. With increased needs for chemical assessments coupled with more diverse data streams from new technologies, regulators and others tasked with chemical management activities are faced with increasing workloads and more diverse types of data to consider. The Adverse Outcome Pathway (AOP) framework can be applied in different scenarios to integrate data and guide chemical assessment and management activities. In this paper, scenarios of how AOPs can be used to guide chemical management decisions during research and development, chemical registration, and subsequent regulatory activities such as prioritization and risk assessment are considered. Furthermore, specific criteria (e.g., the type and level of AOP complexity, confidence in the AOP, as well as external review and assay validation) are proposed to examine whether AOPs and associated tools are fit for purpose when applied in different contexts. Certain toxicity pathways are recommended as priority areas for AOP research and development, and the continued use of AOPs and defined approaches in regulatory activities are recommended. Furthermore, a call for increased outreach, education, and enhanced use of AOP databases is proposed to increase their utility in chemicals management. Integr Environ Assess Manag 2019;15:633-647. © 2019 The Authors. Integrated Environmental Assessment and Management published by Wiley Periodicals, Inc. on behalf of Society of Environmental Toxicology & Chemistry (SETAC).

Indexed as

Government RegulationHazardous SubstancesAdverse Outcome PathwaysDatabases, FactualDecision MakingEcotoxicologyEnvironmental PolicyHumansRisk AssessmentHazardous SubstancesAdverse outcome pathwayChemical decision makingDefined approachesFit for purposeRegulatory science

Identifiers

PMID30908812
PMCPMC6771501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.